Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seradyn is a biotechnology company specializing in the development and manufacture of microparticles and diagnostic reagents for the global healthcare market. The company is widely recognized for its expertise in uniform polymer microparticles, including latex and magnetic beads, which are essential components in immunoassay development and molecular biology. Seradyn's product line features the Quantitative Microsphere System (QMS) used for therapeutic drug monitoring and various assays for drugs of abuse. In 2006, the company was acquired by Thermo Electron Corporation for $94 million, becoming part of what is now Thermo Fisher Scientific. Its technologies continue to serve as a foundation for diagnostic platforms within Thermo Fisher's clinical diagnostics portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seradyn.